Follow Arbutus Biopharma Corp. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.
5 Stories in coverage 0 Programs 0 Registered trials Nov 10 Latest story
Timeline 5 Pipeline 0 Trials 0
All5 Regulatory1 Filings and people4
Details
Headquarters Warminster, PA Incorporated British Columbia, Canada Industry Pharmaceutical Preparations Formerly TEKMIRA PHARMACEUTICALS CORP (to 2015); TEKMIRA PHARMACEUTICALS Corp (to 2015) Also known as ABUS, TEKMIRA PHARMACEUTICALS CORP How the company describes itself Arbutus Biopharma develops treatments for chronic hepatitis B infection, including imdusiran (AB-729) and an oral PD-L1 inhibitor (AB-101), both in clinical stage. The company is based in Canada and holds patents on lipid nanoparticle technology. source